How does Malarone prevent malaria at the molecular level?

Malarone pairs atovaquone, which blocks the parasite’s mitochondrial electron transport chain, with proguanil, which inhibits dihydrofolate reductase; together they stop Plasmodium parasites from reproducing and maturing in the bloodstream.

What are the most common side effects of Malarone and who should not use it?

Typical side effects include nausea, abdominal pain, headache, and insomnia; the drug should be avoided or used with caution in patients with severe kidney or liver impairment, pregnant or breastfeeding women, and individuals with a known hypersensitivity to atovaquone or proguanil.

What is the recommended dosing schedule for Malarone when used for malaria prophylaxis?

One tablet (250 mg/100 mg) should be taken daily with a full meal, beginning 1–2 days before entering a malaria‑endemic area, continued throughout the stay, and for seven days after leaving the area to ensure complete protection.

GlaxoSmithkline • 12 comprimés

Malarone 250 mg/100mg

Health Beauty

Product Insights

Malarone 250 mg/100 mg is a fixed‑dose tablet combining atovaquone and proguanil, designed to prevent and treat malaria caused by Plasmodium species. The medication is praised for its once‑daily dosing, high efficacy, and convenient blister packaging, but it requires a medical prescription, may cause side effects such as nausea, headache, or abdominal discomfort, and is contraindicated in certain populations like those with severe kidney or liver disease. It is manufactured by GlaxoSmithKline in Spain and should be taken with food to ensure optimal absorption.

Comparative Analysis

Malarone holds a leading position in the antimalarial market as a convenient, high‑efficacy, once‑daily combination therapy, distinguishing itself from older regimens like chloroquine and mefloquine through better tolerability and a lower resistance profile.